臺北榮民總醫院

:::

胡啟民 (Chii-Min Hwu)

掛號

[簡介]

學歷

國立陽明交通大學醫學院醫學系內科教授

國立陽明大學醫學院學士

加利福尼亞大學洛杉磯分校臨床流行病學暨預防醫學科進修
經歷
現職：
- - 迄今臺北榮民總醫院內分泌暨新陳代謝科科主任
- - 迄今臺北榮民總醫院內科部新陳代謝科主治醫師
- - 迄今國立陽明大學內科副教授
經歷：
- - 臺北榮民總醫院內科部總醫師
- - 臺北榮民總醫院內科部新陳代謝科住院醫師
醫療專長
1. 糖尿病學、內分泌生理學
證照

中華民國內科專科醫師中華民國糖尿病學會專科醫師中華民國內分泌學會專科醫師

[著作]

First author:

Hwu CM*, Lin YC, Lin KH. β-Cell function in postmenopausal women with isolated post-challenge hyperglycemia. J Diabetes. 2018;10:158-165. [IF: 4.610]

通訊作者:

Yen FS, Wang HC, Pan CW, Wei JC, Hsu CC, Hwu CM*. Pioglitazone Exposure Reduced the Risk of All-Cause Mortality in Insulin-Treated Patients with Type 2 Diabetes Mellitus. J Clin Endocrinol Metab. 2020 1;105:dgz026. [IF: 6.134]

Yen FS, Wei JC, Chiu LT, Hsu CC, Hou MC, Hwu CM*. Thiazolidinediones were associated with higher risk of cardiovascular events in patients with type 2 diabetes and cirrhosis. Liver Int. 2021;41:110-122. [IF: 8.754]

Yen FS, Wei JC, Yang YC, Hsu CC, Hwu CM*. Thiazolidinedione Use in Individuals With Type 2 Diabetes and Chronic Obstructive Pulmonary Disease. Front Med (Lausanne). 2021 9;8:729518. [IF: 5.058]

Chen CN, Chen TC, Tsai SC, Hwu CM*. Factors associated with relative muscle strength in patients with type 2 diabetes mellitus. Arch Gerontol Geriatr. 2021;95:104384. [IF: 4.163]